Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • IdahoRAD
    Junior Member
    • Jan 2014
    • 9

    Annealing adapters

    Hello all--

    I work on preparing RAD libraries, and have a question regarding annealing adapters.

    Suppose my adapters' top and bottom oligos are each at a stock concentration of 100 uM. If I pool each adapter equi-molarly prior to annealing, will I have 100 uM of annealed adapter or will I have 200 uM of annealed adapter?

    Of course, I am simplifying my question, because the thing that is confusing me is the molarity-result of pooling equi-molarly. I have searched for an answer, to no avail! I know this is a basic question, but it has really been stumping me!

    Thank you,

    Cody
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    You will need concentrated annealing buffer to dilute your oligos for maximum annealing. In the simplest form if you just mix equal volume of 100 uM oligos you will get 50 uM adapters.

    Comment

    • IdahoRAD
      Junior Member
      • Jan 2014
      • 9

      #3
      Nucacidhunter--

      Thank you for your reply. Would you mind explaining your rationale, in the example you gave above? Is it because if we pool equi-molarly, we are doubling the volume and thus the molarity decreases?

      Suppose I pooled 100 umol of each component of the adapter, will I thus have 100 umol of annealed adapter?

      The person who was in charge of adapter preparations at my institution left rather abruptly, so I am trying to figure this out on my own. Seems like with these simple protocols, we (at UIdaho) take them for granted until we have to do them ourselves!

      Comment

      • nucacidhunter
        Jafar Jabbari
        • Jan 2013
        • 1250

        #4
        If X mole of oligo A and B is annealed (the same molar concentration) it will give X mole of adapter. In the process the volume has increased by 2x, so the concentration will decrease by 1/2x.

        Comment

        • kerplunk412
          Senior Member
          • Jun 2012
          • 119

          #5
          In case you are looking for second opinions, I completely agree with nucacidhunter.

          Comment

          Latest Articles

          Collapse

          • mylaser
            Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by mylaser
            Kheloyaar: The Complete Guide to Kheloyaar Loginand Kheloyaar ID
            The online gaming industry has transformed the way people enjoy digital entertainment. As technology continues to improve, players are looking for platforms that offer convenience, security, and a seamless user experience. Kheloyaarhas gained attention among users who value an easy-to-use platform, quick account access, and a simple registration process.
            Whether you're exploring Kheloyaar for the first time or want to understand...
            Yesterday, 09:27 PM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            Yesterday, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 10:04 AM
          0 responses
          8 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          7 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-07-2026, 11:05 AM
          0 responses
          11 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-02-2026, 11:08 AM
          0 responses
          31 views
          0 reactions
          Last Post SEQadmin2  
          Working...